Research platform investigating volatile organic compound (VOC)-mediated plant-microbe and microbe-microbe interactions in the rhizosphere to enhance biocontrol efficacy, support sustainable crop protection, and inform chemical ecology-based strategies that reduce reliance on synthetic pesticides.
This solution addresses the growing need for sustainable alternatives to synthetic pesticides by advancing the understanding of volatile organic compound (VOC)-mediated interactions in the rhizosphere, the soil region surrounding plant roots. The research focuses on how plant- and microbe-secreted metabolites mediate pathogen defense, pathogen suppression, and plant growth stimulation. By characterizing these chemical signals, the platform supports the development of robust biocontrol strategies and chemical ecology-based crop protection approaches that improve plant health and reduce dependence on conventional chemical inputs.
Core research capabilities:
The platform is at an advanced research stage with established expertise in VOC-mediated interactions and ongoing development of experimental systems. Current validation includes demonstrated effects of fungal VOCs on plant root manipulation and bacterial-fungal VOC interactions. Future validation efforts will build improved soil-based experimental systems to investigate multitrophic interactions, assess VOC profiles as health indicators, and examine the influence of crop diversity and cultural practices on these chemical ecology processes. The research is positioned to guide the development and deployment of practical biocontrol and crop protection strategies.
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.